Found: 9
Select item for more details and to access through your institution.
Diabetic fatty liver disease is associated with specific changes in blood-borne markers.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2012, v. 28, n. 4, p. 343, doi. 10.1002/dmrr.2269
- By:
- Publication type:
- Article
Reply to Verougstraete et al. Comment on HbA<sub>1c</sub> determination from HemaSpot blood collection devices: comparison of home‐prepared dried blood spots with standard venous blood analysis.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 9, p. 1614, doi. 10.1111/dme.14296
- By:
- Publication type:
- Article
HbA<sub>1c</sub> determination from HemaSpot™ blood collection devices: comparison of home prepared dried blood spots with standard venous blood analysis.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 9, p. 1463, doi. 10.1111/dme.14110
- By:
- Publication type:
- Article
A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 11, p. 1314, doi. 10.1111/dme.12228
- By:
- Publication type:
- Article
Blood Rheology and Albumin Excretion in Diabetic Pregnancy.
- Published in:
- Diabetic Medicine, 1995, v. 12, n. 1, p. 51, doi. 10.1111/j.1464-5491.1995.tb02062.x
- By:
- Publication type:
- Article
Do Rheological Variables Play a Role in Diabetic Peripheral Neuropathy?
- Published in:
- Diabetic Medicine, 1991, v. 8, n. 3, p. 232, doi. 10.1111/j.1464-5491.1991.tb01578.x
- By:
- Publication type:
- Article
Association of Hypertension with Blood Viscosity in Diabetes.
- Published in:
- Diabetic Medicine, 1988, v. 5, n. 9, p. 830, doi. 10.1111/j.1464-5491.1988.tb01119.x
- By:
- Publication type:
- Article
Diabetic Ketoacidosis During NovoPen Therapy.
- Published in:
- Diabetic Medicine, 1988, v. 5, n. 1, p. 87, doi. 10.1111/j.1464-5491.1988.tb00949.x
- By:
- Publication type:
- Article
Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0178171
- By:
- Publication type:
- Article